|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Mucormycosis in hematologic malignancies:an emerging fungal infection显示文摘 | NOSARI A ORESTE P MONTILLO M | 2000 | Haematologica2000，85，10： | 1 |
| 2 | Mucormycosis in he- matologic malignancies: an emerging fungal infection 显示文摘 | Nosari AP Oreste M Montillo G | 2000 | Haematologica2000，85，10： | 1 |
| 3 | Alemtuzumab in the treat- ment of fludarabine refractory B-cell chronic lymphocytic leukemia (CLL) 显示文摘 | Montillo M Ricci F Miqueleiz S | 2008 | Biologics2008，2，1： | 1 |
| 4 | Fludarabine,cytarabine,and G-CSF (FLAG) for the treatment of poor risk acute myeloid leukemia显示文摘 | MONTILLO M MIRTO S PETTI MC | 1998 | Am J Hematol1998，58，2： | 1 |
| 5 | Chronic lymphoctie leukemia: novel prognostic and their relevance for risk -adapted therapeutic strategies 显示文摘 | Montillo M Hamblin T Hallek M | 2005 | Haematologica2005，90，3： | 1 |
| 6 | Twice daily fludarabine/Ara-C associated to idarubicin, G-CSF and ATRA is an effective salvage regimen in non-promyelocytic acute myeliod leukemia 显示文摘 | Montillo M Ricci F Tedeschi A | 2009 | Leuk Res2009，33，8： | 1 |
| 7 | Mucormycosis in hematologic malignancies: an emerging fungal infection 显示文摘 | Nosari A Oreste P Montillo M | 2000 | Haematologica2000，85，10： | 1 |
| 8 | Eradication of minimal re sidual disease with alemtuzumab in B-cell chronic lymphocytic leukemia (B-CLL) patients: the need for a standard method of detection and the potential impact of bone marrow clearance on disease outcome 显示文摘 | Montillo M Schinkocthe T Elter T | 2005 | Cancer Invest2005，23，6： | 1 |
| 9 | Mucormycosis in hematologic malignancies:an emerging fungal infection显示文摘 | Nosari A Oreste P Montillo M | 2000 | Haematologica2000，85，10： | 1 |
| 10 | Fludatabine, cytarabine, and G-CSF (FLAG) for the treatment of poor risk acute myeloid leukemia显示文摘 | Montillo M Mirto S Petti MC | 1998 | Am J Hematol1998，58，： | 1 |
| 11 | Fludarabine, cytarabine, and G-CSF (FLAG) for the treament of poor risk acute myeloid leukemia显示文摘 | Montillo M Mirto S Petti Mc | 1998 | Am J Hematol1998，58，： | 1 |
| 12 | Twice daily fludarabine/Ara-C associated to idarubicin, G-CSF and ATRA is an effective salvage regimen in non-promyelocytic acute myeloid leukemia 显示文摘 | MONTILLO M RICCI F TEDESCHI A | 2009 | Leuk Res2009，33，8： | 1 |
| 13 | Chronic lymphocytic leu- kemia:novel prognostic factors and their relevance for risk-adapted therapeutic strategies显示文摘 | Montillo M Hamblin T Hallek M | 2005 | Haematoloqica2005，90，3： | 1 |
| 14 | Chronic lymphocytic leukemia:novel prognostic and their relevance for risk-adapted therapeutic strategies显示文摘 | Montillo M Hamblin T Hallek M | 2005 | Haematologica2005，90，3： | 1 |
| 15 | ZAP-70, IgVh, and cy- togenedcs for assessing prognosis in chronic lymphocytic leukemia显示文摘 | Trojani A Montillo M Nichelatti M | 2009 | Cancer Biomark2009，6，1： | 1 |
| 16 | Final Results from the Phase IIa Study of the Anti - CXCL12 Spiegelmer? Olaptesed Pegol (NOX- A12 ) in Combination with Bort- ezomib and Dexamethasone in Patients with Multiple Mye- loma 显示文摘 | Steurer M Scarfo L Montillo M | 2013 | Blood ( ASH annual meeting Abstracts)2013，123，： | 1 |
| 17 | Therapy-Related Myeloid Neoplasms in Chronic Lymphocytic Leukemia and Waldenstromg Macroglobulinemia显示文摘 | Ricci F Tedeschi A Montillo M | 2011 | Mediterr J Hematol In- fect Dis2011，3，1： | 1 |
| 18 | ZAP-70, IgVh, and cytogenetics for assessing prognosis in chronic lymphocytic leukemia 显示文摘 | Trojani A Montillo M Niehelatti M | 2010 | Cancer Biomark2010，6，1： | 1 |
| 19 | Role of fludarabine in hematological malignancies显示文摘 | Montillo M Ricci F Tedeschi A | 2006 | Expert Rev Anticancer Ther2006，6，9： | 1 |
| 20 | Fludarabine, cytarabine, and G-CSF(FLAG) for the treatment of poor risk acute myeloid leukemia 显示文摘 | MONTILLO M MIRTO S PETTI M C | 1998 | Am J Hematol1998，58，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员